0002.KLSE Kotra Industries Bhd

Healthcare Pharmaceuticals Kuala Lumpur Exchange
Add to portfolio Ask AI about 0002.KLSE
3.75 MYR
Close of Oct 29, 2026
3.65 4.31
Market cap
MYR 556M
P/E
13.9x
P/B
1.91x
ROE
14.2%
Dividend yield
5.87%
Fundamental score
3.0/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0002.KLSE undervalued?

Graham number
Price3.75
Graham value3.46
Premium8.4%

0002.KLSE trades 8.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kotra Industries Bhd fundamental analysis

14 of 22 checks passed

ROE 1/2

Moderate return on equity (14.2%), between 10% and 20%.

ROA 1/1

Return on assets (10.9%) is above the industry median (5.5%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-4.4%) is not above the 5-year average (10.6% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-4.4%) is below the industry median (15.6%).

Revenue Growth 0/2

Revenue shrank 1.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (8.6%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 116.7x against interest expense, well covered.

PE vs Market 0/1

PE (13.9x) is above the market median (11.4x).

PE vs Industry 1/1

PE (13.9x) is below the industry median (16.6x).

PBV 0/1

Price to book (1.9x) is above the industry median (0.9x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 26.5, limit 22.5).

PEG 0/1

PEG on 5-year earnings growth is 1.31, above 1.

Dividend Yield 2/2

Dividend yield (5.9%) is in the top 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 80.4%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About Kotra Industries Bhd

Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and senior citizens. It also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology under the Axcel brand; sterile antib…

Full company profile